| Table 2: Medications of the participants. |
| | Treatment | No. of patients (%) |
| | NSAIDs | 10 (50) | | COX-II inhibitors | 2 (10) | | Methotrexate (MTX) | 10 (50) | | Sulphasalazine (SSZ) | 2 (10) | | MTX and SSZ | 5 (40) | | Gold | 1 (5) |
|
|
NSAIDs: Nonsteroidal anti-inflammatory drugs, COX-II: cyclo-oxygenase II.
|